BioCardia, Inc.
BCDA
$2.23
-$0.02-0.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | -- | 3.00K | 55.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 0.00 | -- | 3.00K | 55.00K |
| Cost of Revenue | 1.53M | -1.56M | 931.00K | 800.00K | 1.24M |
| Gross Profit | -1.53M | 1.56M | -931.00K | -797.00K | -1.19M |
| SG&A Expenses | 1.20M | 906.00K | 825.00K | 852.00K | 1.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.73M | 2.32M | 1.76M | 1.65M | 2.33M |
| Operating Income | -2.73M | -2.32M | -1.76M | -1.65M | -2.28M |
| Income Before Tax | -2.71M | -2.30M | -1.74M | -1.65M | -2.27M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.71M | -2.30M | -1.74M | -1.65M | -2.27M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.71M | -2.30M | -1.74M | -1.65M | -2.27M |
| EBIT | -2.73M | -2.32M | -1.76M | -1.65M | -2.28M |
| EBITDA | -2.71M | -2.31M | -1.74M | -1.63M | -2.26M |
| EPS Basic | -0.59 | -0.50 | -0.61 | -0.88 | -1.35 |
| Normalized Basic EPS | -0.37 | -0.31 | -0.38 | -0.55 | -0.85 |
| EPS Diluted | -0.59 | -1.00 | -0.61 | -0.88 | -1.35 |
| Normalized Diluted EPS | -0.37 | -0.31 | -0.38 | -0.55 | -0.85 |
| Average Basic Shares Outstanding | 4.64M | 4.59M | 2.83M | 1.88M | 1.68M |
| Average Diluted Shares Outstanding | 4.64M | 4.59M | 2.83M | 1.88M | 1.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |